Le Corre P, Estèbe J P, Chevanne F, Mallédant Y, Le Verge R
Laboratoire de Pharmacie Galénique et Biopharmacie, Faculté des Sciences Pharmaceutiques et Biologiques, Université de Rennes I, France.
J Pharm Sci. 1995 Jan;84(1):75-8. doi: 10.1002/jps.2600840118.
Bupivacaine-loaded microspheres made from DL-polylactic acid oligomers of different molecular weights (MW 2000 and 9000 g/mol, named PLA 2000 and PLA 9000, respectively) which displayed different in vitro release profiles were administered via the spinal route to rabbits. In comparison to the drug administered as a solution (2 mg as equivalent base), PLA 2000 and PLA 9000 microspheres (10 mg as equivalent base) led to a slower uptake of the drug in the systemic circulation, as suggested by the mean maximal plasma concentrations: 326 +/- 81, 321 +/- 57 and 64 +/- 54 ng/mL, respectively. Pharmacodynamic evaluation of the anesthetic action, by means of intensity and time course of motor blockade, indicated a sustained release. In comparison to the drug solution, the PLA 2000 microspheres led to an increase duration of median maximal blockade (172 min versus 44.5 min). The PLA 9000 microspheres failed to reach maximal blockade as a result of a too low release rate.
由不同分子量(分别为2000和9000 g/mol,命名为PLA 2000和PLA 9000)的DL - 聚乳酸低聚物制成的载布比卡因微球,其体外释放曲线不同,通过脊髓途径给予兔子。与作为溶液给药的药物(相当于碱基2 mg)相比,PLA 2000和PLA 9000微球(相当于碱基10 mg)导致药物在体循环中的摄取较慢,平均最大血浆浓度分别为:326 +/- 81、321 +/- 57和64 +/- 54 ng/mL表明了这一点。通过运动阻滞的强度和时间进程对麻醉作用进行的药效学评估表明有持续释放。与药物溶液相比,PLA 2000微球使最大阻滞持续时间增加(172分钟对44.5分钟)。由于释放速率过低,PLA 9000微球未能达到最大阻滞。